Eversana expands Asian footprint with four new offices

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Andrey Tolkachev)
(Image: Getty/Andrey Tolkachev)

Related tags: Eversana, Commercialization, Service provider, Asia, Asia pacific

Eversana looks to enhance its service in Asia and meet ‘increased’ demand with new offices in Singapore, Mumbai, Shanghai, and Tokyo.

The company, which develops software services for drug commercialization, announced the opening of its offices in Singapore and Mumbai, with the concurrent appointment of a regional leadership team which will be based in Singapore.

Additionally, Eversana announced plans to open offices in Shanghai and Tokyo by the end of 2019, along with an intention to invest ‘significant’ capital resources to build its regional footprint.

According to the company, this move answers an increased need for global solution capabilities for companies headquartered in Asia, as well as US and European headquartered companies looking to bring solutions to the Asian markets.

Jim Lang, CEO of Eversana, commented in a statement that China and Japan are now the second and third largest life sciences markets and “are widely regarded as vital contributors to the future of precision medicine.”

The company already has offices in 25 locations across North America, Europe and Asia, and employs more than 2,000 people.

Eversana also recently announced an agreement​ to adopt Cryoport’s cold chain logistics services for regenerative medicines.

Related news

Show more

Related products

show more

Paper vs ePRO Data Collection Methods

Paper vs ePRO Data Collection Methods

Signant Health | 19-Oct-2021 | Technical / White Paper

Are you curious why more Sponsors choose digital data collection methods over the traditional pen and paper? Read this recent white paper to discover the...

GLP Tissue Cross Reactivity Testing

GLP Tissue Cross Reactivity Testing

Precision for Medicine | 11-Oct-2021 | Product Brochure

Precision for Medicine's unique combination of research services and tissue procurement capabilities form the pillars of our GLP Tissue Cross Reactivity...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us


View more